Company
Novo Nordisk
NYSE:NVO
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
225 stories · page 3 of 3
Novo Nordisk Wegovy surge to continue, says Stifel
Novo Nordisk delivered 30% and 32% growth in sales and operating income respectively in the first half
‘Miracle’ weight-loss drug Wegovy will not be issued through major insurers
Aviva, Axa, and WPA snub the obesity drug
FIVE at FIVE: Pret prices; National Grid plans 12 switch offs; Superdried up; Novo Nordisk’s fat buster; FTSE 100
Here’s Proactive’s round-up of the top financial stories of the day, with helpful links taking you directly to the news
Novo Nordisk weight-loss drug impresses in heart trial
Shares jumped 10% as cardiovascular events were cut by a fifth in Select trial
Aeterna Zentaris sees revenue boost in 3Q, ends the quarter debt-free
Its product Macimorelin is used in the diagnosis of adult growth hormone deficiency
PRE-MARKET MOVERS: Stitch Fix shoots higher in pre-market, but Lam Research Corp lags
Retailer Zumiez Inc and diabetes- focuse manufacturer Novo Nordisk were also in the frame
US stocks fall across the board
Traders' screens are a sea of red, after global markets were rattled by more evidence of China's economic growth engine seizing up.
Bid activity lightens an otherwise somber mood in U.S. markets
Some financial engineering - mergers, demergers and stake-building - is keeping investors interested in some stocks, but otherwise it has been a weak start to the week.
Archive
US stocks dive despite continued M&A activity
Some financial engineering - mergers, demergers and stake-building - is keeping investors interested in some stocks, but otherwise it has been a weak start to the week.